These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8014851)

  • 1. Analgesic potency of mu and kappa opioids after systemic administration in amphibians.
    Stevens CW; Klopp AJ; Facello JA
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1086-93. PubMed ID: 8014851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians.
    Stevens CW
    J Pharmacol Exp Ther; 1996 Feb; 276(2):440-8. PubMed ID: 8632308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
    Stevens CW; Rothe KS
    Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1991 Nov; 259(2):582-9. PubMed ID: 1658305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and spinal administration of the mu opioid, remifentanil, produces antinociception in amphibians.
    Mohan S; Stevens CW
    Eur J Pharmacol; 2006 Mar; 534(1-3):89-94. PubMed ID: 16487509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic potency of alpha adrenergic agents after systemic administration in amphibians.
    Brenner GM; Klopp AJ; Deason LL; Stevens CW
    J Pharmacol Exp Ther; 1994 Aug; 270(2):540-5. PubMed ID: 7915313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL; Martin ZL; Smith FL; Welch SP
    J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
    Liguori A; Morse WH; Bergman J
    J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
    Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
    Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
    Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiation of antinociceptive effects of mu, delta and kappa agonists using heat, chemical and mechanical nociception].
    Murakawa K; Noma K; Matsuda M; Maeda S; Tashiro C; Izumi R
    Masui; 1996 Aug; 45(8):937-42. PubMed ID: 8818088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
    Ulens C; Van Boven M; Daenens P; Tytgat J
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.